Togaviridae Disease
Symptoms, Doctors, Treatments, Advances & More

Togaviridae Disease Overview

Save information for later
Sign Up

Learn About Togaviridae Disease

What is the definition of Togaviridae Disease?
Togaviridae disease is a term used to describe a family of viruses grouped into two categories: Alphavirus and Rubivirus. Alphaviruses are spread primarily by mosquitoes and other insects, spiders, or crustaceans to humans and cause arthritis and encephalitis. Rubivirus, commonly known as Rubella, causes the childhood disease and is transmitted through airborne aerosol droplets.
What are the symptoms of Togaviridae Disease?
Symptoms of alphaviruses can include flu-like symptoms, fever, arthritis, headache, pain, muscle pain, rash, encephalitis, and/or other further complications. Symptoms of Rubella include fever, joint pain, headache, rash, and swollen glands (lymph nodes).
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Togaviridae Disease?
Treatment for Togaviridae disease is mainly supportive care that addresses symptoms or complications. Other methods of prevention include vector-control and protecting against mosquito bites.
Who are the top Togaviridae Disease Local Doctors?
Elite in Togaviridae Disease
Johan Neyts
Elite in Togaviridae Disease
Johan Neyts
Referral may be required
Leuven, VLG, BE 

Johan Neyts practices practicing medicine in Leuven, Belgium. Mr. Neyts is rated as an Elite expert by MediFind in the treatment of Togaviridae Disease. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Yellow Fever, Hepatitis E, Viral Hemorrhagic Fever, Parainfluenza Virus Type 3, and Lung Transplant.

Advanced in Togaviridae Disease
Dr. Donald J. Weaver
Pediatric Nephrology
Advanced in Togaviridae Disease
Dr. Donald J. Weaver
Pediatric Nephrology
Referral may be required

Atrium Health Levine Children's Nephrology

1001 Blythe Blvd., Suite C, 
Charlotte, NC 
704-381-8800
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Donald Weaver is a Pediatric Nephrologist practicing medicine in Charlotte, North Carolina. Dr. Weaver is rated as an Advanced provider by MediFind in the treatment of Togaviridae Disease. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Posterior Urethral Valves, Togaviridae Disease, Feingold Syndrome, and Congenital Nephrotic Syndrome. Dr. Weaver is board certified in American Board Of Pediatrics and American Board Of Pediatrics, Pediatric Nephrology. Dr. Weaver is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Togaviridae Disease
Dr. Gregory Poland
Internal Medicine
Elite in Togaviridae Disease
Dr. Gregory Poland
Internal Medicine

Mayo Clinic-Rochester

5716 Cleveland St Ste 200, 
Virginia Beach, VA 
507-284-2511
Languages Spoken:
English
See accepted insurances

Gregory Poland is a primary care provider, practicing in Internal Medicine in Virginia Beach, Virginia. Dr. Poland is rated as an Elite provider by MediFind in the treatment of Togaviridae Disease. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Rubella, Togaviridae Disease, Smallpox, and Measles.

View All Doctors
What are the latest Togaviridae Disease Clinical Trials?
A Phase 3a, Observer-blind, Randomized, Controlled Study to Evaluate the Safety of an Investigational Varicella Vaccine Compared With Varivax, Administered as a First Dose to Healthy Children 12 to 15 Months of Age
A Phase 3a, Observer-blind, Randomized, Controlled Study to Evaluate the Safety of an Investigational Varicella Vaccine Compared With Varivax, Administered as a First Dose to Healthy Children 12 to 15 Months of Age
Enrollment Status: Recruiting
Publish Date: May 29, 2026
Intervention Type: Biological
Study Phase: Phase 3

Summary: The purpose of this study is to assess how well-tolerated GSK's investigational varicella vaccine (VNS Vaccine) is, in comparison to an already approved varicella vaccine (VV) known as Varivax. The study will be conducted on healthy children aged 12 to 15 months, and who have neither contracted varicella nor received a varicella vaccination.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Randomized, Observer-Blind, Placebo-Controlled, Proof-of-Concept Study to Assess the Safety, Tolerability and Immunogenicity of a Bivalent Human Papillomavirus (HPV) Vaccine in 9 and 15 Month Old Infants and Toddlers, 2-5 Year Old Children and an Open Label Single Dose Study in Young Unmarried Females Aged 15-20 Years in Ghana
A Randomized, Observer-Blind, Placebo-Controlled, Proof-of-Concept Study to Assess the Safety, Tolerability and Immunogenicity of a Bivalent Human Papillomavirus (HPV) Vaccine in 9 and 15 Month Old Infants and Toddlers, 2-5 Year Old Children and an Open Label Single Dose Study in Young Unmarried Females Aged 15-20 Years in Ghana
Enrollment Status: Recruiting
Publish Date: May 18, 2026
Intervention Type: Biological
Study Phase: Phase 2

Summary: This is a randomized observer-blind placebo-controlled proof-of-concept study with the aim to assess the safety and tolerability, and the immunogenicity of a bivalent HPV vaccine administered in healthy infants and toddlers (9- and 15-month-olds) comparing them to an immune-bridging population of 15-20-year-old unmarried females in an open label study in Ghana at the Dodowa Health Research Center.

View All Clinical Trials